Notably, while ErbB4 deletion predisposes mice to metabolic alterations implicated in obesity, NRG1 administration is known to improve metabolic health in obese mice by lowering blood glucose, improving insulin sensitivity, and reducing caloric intake [47, 57, 102]. This evidence concerns the gene INS and obesity disorder.